AstraZeneca’s Oft-Failed Cancer Combo Succeeds in Lung Trial

(Bloomberg) -- AstraZeneca Plc’s novel combination of cancer treatments succeeded in a final-stage study, showing utility against lung tumors after a string of failures.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.